Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Circulation of Penicillin in SpainA Promising Drug: Bacteria, Antibiotics and Marketing in an Era of Economic Development

The Circulation of Penicillin in Spain: A Promising Drug: Bacteria, Antibiotics and Marketing in... [On February 15, 1991, the weekly pages devoted to medicine and health in the Barcelona daily newspaper, La VanguardiaLa Vanguardia, included a brief report on the effects of the antibiotic fosfomycinFosfomycin characteristics in the treatment of urinary infections. The new antibiotic isolated and identified as part of the research programme was named phosphonomycin, later changed to fosfomycin and finally, for marketing within Spain, fosfocina. In this chapter, I relate the story of an expectation fulfilled by the production of a new drug, developed in the factory, the clinic and the research laboratory. The long life of this antibiotic, later retrieved and promoted for the treatment of urinary infections as if a recent discovery, began as the result of the new methods of detecting antimicrobial activity introduced in the early 1960s precisely as an outcome of the research on the action mechanism of penicillin in bacteria, transferred from a US laboratory to a Spanish pharmaceutical firm.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

The Circulation of Penicillin in SpainA Promising Drug: Bacteria, Antibiotics and Marketing in an Era of Economic Development

Download PDF
29 pages

Loading next page...
 
/lp/springer-journals/the-circulation-of-penicillin-in-spain-a-promising-drug-bacteria-bBtSiTnF49

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s) 2018
ISBN
978-3-319-69717-8
Pages
133 –162
DOI
10.1007/978-3-319-69718-5_6
Publisher site
See Chapter on Publisher Site

Abstract

[On February 15, 1991, the weekly pages devoted to medicine and health in the Barcelona daily newspaper, La VanguardiaLa Vanguardia, included a brief report on the effects of the antibiotic fosfomycinFosfomycin characteristics in the treatment of urinary infections. The new antibiotic isolated and identified as part of the research programme was named phosphonomycin, later changed to fosfomycin and finally, for marketing within Spain, fosfocina. In this chapter, I relate the story of an expectation fulfilled by the production of a new drug, developed in the factory, the clinic and the research laboratory. The long life of this antibiotic, later retrieved and promoted for the treatment of urinary infections as if a recent discovery, began as the result of the new methods of detecting antimicrobial activity introduced in the early 1960s precisely as an outcome of the research on the action mechanism of penicillin in bacteria, transferred from a US laboratory to a Spanish pharmaceutical firm.]

Published: Dec 20, 2017

Keywords: Fosfomycin; protoplastsProtoplasts; Gram-negative bacteriaGram-negative Bacteria; patentPatent; Sagrario

There are no references for this article.